Introducing Empagliflozin N-1, the innovative pharmaceutical product brought to you by Shanghai Lizhuo Pharmaceutical Technology Co., Ltd., a renowned manufacturer, supplier, and factory based in China. Empagliflozin N-1 is a cutting-edge medication specifically designed to effectively manage and treat diabetes. As a trusted pharmaceutical company, Shanghai Lizhuo prioritizes the highest quality standards in the manufacturing process of Empagliflozin N-1. Our state-of-the-art facility utilizes advanced technology and adheres to strict industry regulations to ensure the production of a safe and reliable product. Empagliflozin N-1 is formulated with precision and contains powerful ingredients to control blood sugar levels in patients suffering from diabetes. This product functions by inhibiting glucose reabsorption in the kidneys, aiding in the excretion of excess glucose through urine. By acting as a sodium-glucose cotransporter 2 (SGLT2) inhibitor, Empagliflozin N-1 supports better glycemic control, leading to improved health outcomes for diabetic individuals. With its positive impact on diabetes management and the expertise behind its production, Shanghai Lizhuo's Empagliflozin N-1 is poised to make a significant difference in the lives of those living with diabetes. Choose Empagliflozin N-1 for effective and reliable diabetes treatment.